Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 1
2012 1
2013 4
2014 4
2015 5
2018 3
2020 5
2021 3
2022 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Cellular Therapy for Chronic Traumatic Brachial Plexus Injury.
Sharma A, Sane H, Gokulchandran N, Badhe P, Pai S, Kulkarni P, Yadav J, Inamdar S. Sharma A, et al. Among authors: gokulchandran n. Adv Biomed Res. 2018 Mar 27;7:51. doi: 10.4103/2277-9175.228631. eCollection 2018. Adv Biomed Res. 2018. PMID: 29657936 Free PMC article.
Corrigendum to "A pilot study for treatment of COVID-19 patients in moderate stage using intravenous administration of ozonized saline as an adjuvant treatment-registered clinical trial" [Int. Immunopharmacol. 96 (2021) 107743].
Sharma A, Shah M, Lakshmi S, Sane H, Captain J, Gokulchandran N, Khubchandani P, Pradeep MK, Gote P, Tuppekar B, Kulkarni P, Paranjape A, Pradhan R, Varghese R, Kasekar S, Nair V, Khanbande U. Sharma A, et al. Among authors: gokulchandran n. Int Immunopharmacol. 2022 Jan;102:107932. doi: 10.1016/j.intimp.2021.107932. Epub 2021 Jul 15. Int Immunopharmacol. 2022. PMID: 34274220 Free PMC article. No abstract available.
Phase 1 clinical trial for intravenous administration of mesenchymal stem cells derived from umbilical cord and placenta in patients with moderate COVID-19 virus pneumonia: results of stage 1 of the study.
Sharma A, Kulkarni R, Sane H, Awad N, Bopardikar A, Joshi A, Baweja S, Joshi M, Vishwanathan C, Gokulchandran N, Badhe P, Khan M, Paranjape A, Kulkarni P, Methal AK. Sharma A, et al. Among authors: gokulchandran n. Am J Stem Cells. 2022 Jun 15;11(3):37-55. eCollection 2022. Am J Stem Cells. 2022. PMID: 35873716 Free PMC article.
A pilot study for treatment of COVID-19 patients in moderate stage using intravenous administration of ozonized saline as an adjuvant treatment-registered clinical trial.
Sharma A, Shah M, Lakshmi S, Sane H, Captain J, Gokulchandran N, Khubchandani P, Pradeep MK, Gote P, Tuppekar B, Kulkarni P, Paranjape A, Pradhan R, Varghese R, Kasekar S, Nair V, Khanbande U. Sharma A, et al. Among authors: gokulchandran n. Int Immunopharmacol. 2021 Jul;96:107743. doi: 10.1016/j.intimp.2021.107743. Epub 2021 Apr 30. Int Immunopharmacol. 2021. PMID: 33984718 Free PMC article. Clinical Trial.
29 results